Wilson Sonsini Goodrich & Rosati advised Ambarella on the deal. Ambarella, an AI vision silicon company, announced it has entered into a definitive agreement to acquire...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Synthekine on the deal. Synthekine Inc., an engineered cytokine therapeutics company, announced that it has entered into a worldwide research...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Udemy on the deal, while Simpson Thacher represented the underwriters. Udemy announced the pricing of its initial public offering of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Roblox on the deal. Simpson Thacher represented Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC and J.P. Morgan...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Ventyx on the deal. Ventyx Biosciences, a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Arcaea on the deal. Arcaea, a company launched on the Ginkgo Bioworks platform, announced its $78 million Series A to...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Quanta Therapeutics on the deal. Quanta Therapeutics, Inc., a privately held biopharmaceutical company pioneering complex-directed therapies to treat RAS-driven cancer...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented General Atlantic on the transaction. CinCor Pharma, Inc. announced the completion of a $143 million Series B financing. The financing...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Clearway Energy on the deal. Clearway Energy Group LLC announced the start of full construction at its Daggett 3 Solar...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the deal. North Carolina-based mammary biotechnology company BIOMILQ, Inc., announced the successful close of $21 million in...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Crinetics on the deal. Crinetics Pharmaceuticals, a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Plume on the deal. Plume, the creator of the world’s first SaaS experience platform for communications service providers (CSPs) and...
You must be a Standard 1 Year member to access this content.
